Im Buch haben wir einen QR-Code abgedruckt – damit mache ich alle Stimmrechts-Mitteilungen von BlackRock bei Adidas, Allianz, Deutsche Telekom, BMW ... Partners (GIP) gekauft, die neue ...

German carmaker BMW AG is reviewing plans to reintroduce battery-electric Mini production in the UK, due to uncertainties facing the automotive industry. The decision represents a U-turn for the ...

BMW said "multiple uncertainties facing the automotive industry" had led to its decision BMW has confirmed it is delaying the reintroduction of electric vehicle production at its Oxford Mini plant ...

BMW has confirmed it is delaying the reintroduction of electric vehicle production at its Oxford Mini plant. The vehicle manufacturer said "multiple uncertainties facing the automotive industry ...

BMW offers 25 bike models in India, prices start from Rs. 2.90 Lakh for the G 310 R and go upto Rs. 55.00 Lakh for the M 1000 RR. BMW offers a variety of Petrol and Electric powered bikes ...

Historically, BMW coupés have simply been swoopier, less practical versions of their saloon car counterparts. Not any more – the BMW 4 Series is a rakish model in its own right. Sure ...

Three years on, it’s fair to say that the controversy/abject horror that attended the arrival of BMW’s star electric car – the machine that represented the dawning of a radical new era in ...

The Monetary Authority of Singapore (MAS) last month announced adjustments to the Global Investor Programme (GIP) – which grants permanent residency to eligible foreign investors – among other moves ...

Is the BMW 1 Series a good car? The BMW 1 Series remains a solid entry in the premium hatchback segment thanks to its dynamic driving experience, well-built cabin and strong efficiency.

The BMW iX is unquestionably the most radical and technologically advanced BMW electric car since the i3 was revealed more than a decade ago. In fact, you can see the lessons learned from the ...

PASADENA, Kalifornien - Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), aktuell mit einem Marktwert von 2,19 Milliarden US-Dollar, hat kürzlich vielversprechende präklinische Daten für zwei auf RNA-In ...